Inhibitex to Host Conference Call to Report Third Quarter Financial Results on November 4, 2011
October 26 2011 - 5:28PM
Business Wire
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host
a conference call on Friday, November 4, 2011 at 9:00 a.m. EDT to
review the Company’s third quarter financial results and provide an
update on recent corporate developments. The Company will issue a
press release regarding its financial results on the same day,
prior to the conference call.
Webcast Information
To access the conference call, please dial (877) 407-9210
(domestic) or (201) 689-8049 (international). A replay of the call
will be available from 11:00 a.m. Eastern Time on November 4th
until December 4, 2011 at midnight. To access the replay, please
dial (877) 660-6853 (domestic) or (201) 612-7415 (international)
and reference the account # 286 and the conference id # 382037. A
live audio webcast of the call and the archived webcast will be
available in the News and Events section of the Inhibitex website
at http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc. is a biopharmaceutical company focused on
developing products to prevent and treat serious infectious
diseases. The Company’s clinical-stage pipeline currently includes
two Phase 2 development programs; INX-189, a nucleotide polymerase
inhibitor in development for the treatment of chronic hepatitis C
infections and FV-100, a nucleoside analogue in development for the
treatment of shingles-associated pain. The Company also has other
HCV nucleotide polymerase inhibitors in preclinical development and
has licensed the use of its proprietary MSCRAMM® protein platform
to Pfizer for the development of a staphylococcal vaccine, which is
currently being evaluated in a Phase 1/2 clinical trial.
For additional information about the Company, please visit
www.inhibitex.com.
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Inhibitex, Inc. (MM) (NASDAQ:INHX)
Historical Stock Chart
From Jul 2023 to Jul 2024